METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER

Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented. Data of the studies comparing influe...

Full description

Saved in:
Bibliographic Details
Main Authors: B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/686
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227868708536320
author B. N. Garifullin
A. N. Zakirova
F. S. Zarudij
author_facet B. N. Garifullin
A. N. Zakirova
F. S. Zarudij
author_sort B. N. Garifullin
collection DOAJ
description Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented. Data of the studies comparing influence of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment schemes for carvedilol in patients with acute MI are discussed.
format Article
id doaj-art-665ebaa5f6b041888bdc25ea0b2ebfb1
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-665ebaa5f6b041888bdc25ea0b2ebfb12025-08-23T10:00:22ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0154515710.20996/1819-6446-2009-5-4-51-57685METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFERB. N. Garifullin0A. N. Zakirova1F. S. Zarudij2Bashkir State medical UniversityBashkir State medical UniversityBashkir State medical UniversityResults of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented. Data of the studies comparing influence of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment schemes for carvedilol in patients with acute MI are discussed.https://www.rpcardio.online/jour/article/view/686myocardial infarction, beta-blocker, carvedilol, metoprolol
spellingShingle B. N. Garifullin
A. N. Zakirova
F. S. Zarudij
METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
Рациональная фармакотерапия в кардиологии
myocardial infarction, beta-blocker, carvedilol, metoprolol
title METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
title_full METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
title_fullStr METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
title_full_unstemmed METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
title_short METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
title_sort metoprolol and carvedilol in therapy of acute myocardial infarction when and which drug to prefer
topic myocardial infarction, beta-blocker, carvedilol, metoprolol
url https://www.rpcardio.online/jour/article/view/686
work_keys_str_mv AT bngarifullin metoprololandcarvedilolintherapyofacutemyocardialinfarctionwhenandwhichdrugtoprefer
AT anzakirova metoprololandcarvedilolintherapyofacutemyocardialinfarctionwhenandwhichdrugtoprefer
AT fszarudij metoprololandcarvedilolintherapyofacutemyocardialinfarctionwhenandwhichdrugtoprefer